EXPERIENCE OF THE USE OF DEFERASIROX IN PAEDIATRIC PATIENTS WITH TRANSFUSIONAL DEPENDENCY

被引：0
|
作者：
Faci Cristina, Martinez [1 ]
Sanjuan Laura, Murillo [1 ]
Cebrian Flor, Yus [2 ]
Maria Angeles, Montanes Gracia [2 ]
Flores Maria Del Valle, Recasens [2 ]
Iturrate Carmen, Rodriguez-Vigil [1 ]
机构：
[1] Hosp Univ Miguel Servet, Serv Pediat, Zaragoza, Spain
[2] Hosp Univ Miguel Servet, Serv Hematol, Zaragoza, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-320
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [41] Use of spinal anaesthesia in paediatric patients: a single centre experience with 1132 cases
    Puncuh, F
    Lampugnani, E
    Kokki, H
    PEDIATRIC ANESTHESIA, 2004, 14 (07) : 564 - 567
  • [42] The use of flexible laryngeal mask airway for Adenoidectomies: An experience of 814 Paediatric patients
    Ozmete, Ozlem
    Sener, Mesut
    Caliskan, Esra
    Kipri, Meltem
    Aribogan, Anis
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (04) : 823 - 828
  • [43] EFFECT OF DEFERASIROX USE ON THE EDUCATIONAL STATUS OF PATIENTS WITH THALASSAEMIA: A 20-YEAR, SINGLE-CENTER EXPERIENCE
    Fakhredin, Rayan Bou
    Roumi, Joseph
    Ajouz, Josephine
    Moukhadder, Hassan M.
    Aoun, Rita
    Koussa, Suzanne
    Taher, Ali T.
    HAEMATOLOGICA, 2017, 102 : 93 - 93
  • [44] Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience
    Adramerina, Alkistis
    Printza, Nikoleta
    Hatzipantelis, Emmanouel
    Symeonidis, Symeon
    Tarazi, Labib
    Teli, Aikaterini
    Economou, Marina
    BIOLOGY-BASEL, 2022, 11 (02):
  • [45] Deferasirox: pharmacokinetics and clinical experience
    Galanello, Renzo
    Campus, Simona
    Origa, Raffaella
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (01) : 123 - 134
  • [46] Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload
    Cappellini, M. D.
    Taher, A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2391 - 2402
  • [47] Iron chelating efficacy is related to transfusional iron intake in pediatric patients-treated with deferasirox(Exjade®, ICL670)
    Kattarruis, A.
    Paley, C.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 609 - 609
  • [48] Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia (vol 151, pg 504, 2010)
    Ladis, Vassilis
    Berdousi, Helen
    Gotsis, Efstathios
    Kattamis, Antonis
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (01) : 124 - 124
  • [49] Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Porter, John B.
    Kattamis, Antonis
    Taylor, Kerry
    Rose, Christian
    Louw, Vernon J.
    El-Ali, Ali
    Martin, Nicolas
    Gattermann, Norbert
    BLOOD, 2012, 120 (21)
  • [50] EXPERIENCE WITH THE IRON-CHELATOR DEFERASIROX IN SRI LANKAN PATIENTS WITH THALASSEMIA
    Olivieri, Nancy
    Chandrakumaran, Priya
    Jayawardena, Sanasi
    Sabouhanian, Amir
    Premawardhena, Anuja
    Mettananda, Sachith
    Senadeera, Dulanjalee
    Wadanamby, Sandara
    Walgamage, Malsha
    Walgamage, Thilini
    Seneviratne, Prarthana
    Silva, I.
    Hameed, N.
    Bandara, Dayananda
    Nimal, J. M.
    Chan, Helen
    Shanmugananatham, Saambavy
    Deb, Bhumika
    Yamashita, Robert
    Rees, David
    Allen, Angela
    Weatherall, David
    PEDIATRIC BLOOD & CANCER, 2018, 65
12345